Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > So What Now?

<< Previous

Bullboard Posts

Next >>

Comment by Ladysluton Dec 13, 2020 7:36am

221 Views

Post# 32094974

RE:So What Now?

One thing for shure, last week many people knows that deal with Astrazeneca.
The share price went up. If this deal was not good for us we were sitting at 1 cent.
Now we are at 5.5 cents. I think on the 30 december we are going to have a big smile on our faces.
GLTA

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features